• Rocket Pharmaceuticals CEO Gaurav Shah exercised stock options on May 21, 2026, acquiring 76,490 common shares at USD 1.69.
• He sold 55,684 common shares the same day at an average USD 3.09.
• Directly held common shares totaled 1,061,724 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-022894), on May 26, 2026, and is solely responsible for the information contained therein.